These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25866325)

  • 1. Improving arteriovenous fistula patency: Transdermal delivery of diclofenac reduces cannulation-dependent neointimal hyperplasia via AMPK activation.
    MacAskill MG; Watson DG; Ewart MA; Wadsworth R; Jackson A; Aitken E; MacKenzie G; Kingsmore D; Currie S; Coats P
    Vascul Pharmacol; 2015 Aug; 71():108-15. PubMed ID: 25866325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omentin reduces venous neointimal hyperplasia in arteriovenous fistula through hypoxia-inducible factor-1 alpha inhibition.
    Zhui L; Yuling C; Hansheng W; Xiangjie L
    Microvasc Res; 2024 Jul; 154():104688. PubMed ID: 38640999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periadventitial Delivery of Simvastatin-Loaded Microparticles Attenuate Venous Neointimal Hyperplasia Associated With Arteriovenous Fistula.
    Zhao C; Zuckerman ST; Cai C; Kilari S; Singh A; Simeon M; von Recum HA; Korley JN; Misra S
    J Am Heart Assoc; 2020 Dec; 9(24):e018418. PubMed ID: 33283594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year patency rate of native arteriovenous fistulas reconstructed by vascular stripping in hemodialysis patients with venous neointimal hyperplasia.
    Lu FP; Liu LP; Lu ZX
    J Vasc Surg; 2015 Jan; 61(1):192-6. PubMed ID: 25135873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo nanoparticle assessment of pathological endothelium predicts the development of inflow stenosis in murine arteriovenous fistula.
    Cui J; Kessinger CW; McCarthy JR; Sosnovik DE; Libby P; Thadhani RI; Jaffer FA
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):189-96. PubMed ID: 25395614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized Perivascular Therapeutic Approaches to Inhibit Venous Neointimal Hyperplasia in Arteriovenous Fistula Access for Hemodialysis Use.
    Barcena AJR; Perez JVD; Liu O; Mu A; Heralde FM; Huang SY; Melancon MP
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia and hypoxia-inducible factors promote the development of neointimal hyperplasia in arteriovenous fistula.
    Sadaghianloo N; Contenti J; Declemy S; Ambrosetti D; Zdralevic M; Tannour-Louet M; Fabbri L; Pagès G; Bost F; Hassen-Khodja R; Pouysségur J; Jean-Baptiste E; Dardik A; Mazure NM
    J Physiol; 2021 Apr; 599(8):2299-2321. PubMed ID: 33608879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High shear stress attenuated arterial neointimal hyperplasia accompanied by changes in yes-associated protein/jun N-terminal kinase/vascular cell adhesion protein 1 expression.
    Chen F; Luo JF; Wan R
    Vascular; 2023 Feb; 31(1):163-173. PubMed ID: 35038282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Hypoxia and Metabolism in the Development of Neointimal Hyperplasia in Arteriovenous Fistulas.
    Sadaghianloo N; Contenti J; Dardik A; Mazure NM
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anatomical sources of neointimal cells in the arteriovenous fistula.
    Vazquez-Padron RI; Martinez L; Duque JC; Salman LH; Tabbara M
    J Vasc Access; 2023 Jan; 24(1):99-106. PubMed ID: 33960241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperbaric oxygen inhibits venous neointimal hyperplasia following arteriovenous fistulization.
    Li Z; Li M; Li X; Zhang M; Zhao Y; Ren W; Cheng J; Wang X
    Int J Mol Med; 2017 May; 39(5):1299-1306. PubMed ID: 28393184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CorMatrix Wrapped Around the Adventitia of the Arteriovenous Fistula Outflow Vein Attenuates Venous Neointimal Hyperplasia.
    Yang B; Kilari S; Brahmbhatt A; McCall DL; Torres EN; Leof EB; Mukhopadhyay D; Misra S
    Sci Rep; 2017 Oct; 7(1):14298. PubMed ID: 29085001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Developments in Our Understanding of Neointimal Hyperplasia.
    Lee T; Ul Haq N
    Adv Chronic Kidney Dis; 2015 Nov; 22(6):431-7. PubMed ID: 26524947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular remodeling and intimal hyperplasia in a novel murine model of arteriovenous fistula failure.
    Wong CY; de Vries MR; Wang Y; van der Vorst JR; Vahrmeijer AL; van Zonneveld AJ; Roy-Chaudhury P; Rabelink TJ; Quax PH; Rotmans JI
    J Vasc Surg; 2014 Jan; 59(1):192-201.e1. PubMed ID: 23684425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound appearances and histological correlation of native arteriovenous fistula stenoses - A retrospective case series.
    Steiner K; Ramanarayanan S; Metcalfe M; Jeevaratnum P; Selvakumar S; Narula A
    Semin Dial; 2021 May; 34(3):224-228. PubMed ID: 33410525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of wall shear stress in venous neointimal hyperplasia of arteriovenous fistulae.
    Jia L; Wang L; Wei F; Yu H; Dong H; Wang B; Lu Z; Sun G; Chen H; Meng J; Li B; Zhang R; Bi X; Wang Z; Pang H; Jiang A
    Nephrology (Carlton); 2015 May; 20(5):335-42. PubMed ID: 25581663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury.
    Moon MC; Molnar K; Yau L; Zahradka P
    J Vasc Surg; 2004 Jul; 40(1):130-7. PubMed ID: 15218473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial nitric oxide synthase (eNOS) mediates neointimal thickness in arteriovenous fistulae with different anastomotic angles in rats.
    Bai H; Wei S; Xie B; Wang Z; Li M; Qiao Z; Sun P; Wang W
    J Vasc Access; 2022 May; 23(3):403-411. PubMed ID: 33619996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arteriovenous access failure: more than just intimal hyperplasia?
    Rothuizen TC; Wong C; Quax PH; van Zonneveld AJ; Rabelink TJ; Rotmans JI
    Nephrol Dial Transplant; 2013 May; 28(5):1085-92. PubMed ID: 23543595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of a High-Dose Erythropoietin-Stimulating Agent in Hemodialysis Patients is Associated with Late Arteriovenous Fistula Failure.
    Jeong HY; Ko EJ; Kim SH; Lee MJ; Cho HJ; Yang DH; Lee SY
    Yonsei Med J; 2017 Jul; 58(4):793-799. PubMed ID: 28540993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.